| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| GTO ID | GTC3858 |
| Trial ID | NCT06375993 |
| Disease | Lupus Nephritis |
| Altered gene | CD20 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | ADI-001 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Phase 1 Study of ADI-001 Anti-CD20 CAR-engineered Allogeneic Gamma-Delta (γδ) T Cells in Adults With Lupus Nephritis |
| Year | 2024 |
| Country | United States |
| Company sponsor | Adicet Therapeutics |
| Other ID(s) | ADI-202300103 |
| Cohort 1 | |||||||||
|
|||||||||